# International Aids Vaccine Initiative Inc.

Canonical: https://abierto.us/vendors/international-aids-vaccine-initiative-inc-zejbc8jqm3p5

- UEI: ZEJBC8JQM3P5
- CAGE: 44YM6
- Location: New York, NY
- Awards in window: 5 (7 transactions), $926,786 obligated, June 30, 2026 to September 11, 2026

## Awarding agencies

- National Institutes of Health: 4 awards, $926,786
- Office of Assistant Secretary for Preparedness and Response: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $542,308
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $384,698
- 541712 Professional, Scientific, and Technical Services: -$220

## Competition

- Full and Open Competition: 5 awards

## Largest awards

- 75N93019F00131 (delivery order): $449,750, National Institutes of Health Niaid. Purpose: to Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N93019F00131_7529_75N93018D00010_7529/
- 75N93022F00001 (delivery order): $384,698, National Institutes of Health Niaid. Eo 14398, CGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based Hiv Envelope Vaccine. https://www.usaspending.gov/award/CONT_AWD_75N93022F00001_7529_75N93022D00005_7529/
- 75N93021F00001 (delivery order): $92,558, National Institutes of Health Niaid. To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N93021F00001_7529_75N93018D00010_7529/
- 75A50121C00077 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. The Overall Objective of This Contract Is to Advance the Development of Monovalent Vaccines for Prevention of Marburg Virus (Marv) and Sudan Ebolavirus (Sudv) Disease. These Vaccines Are Based on Recombinant Expression of Filovirus Glycoproteins in. https://www.usaspending.gov/award/CONT_AWD_75A50121C00077_7505_-NONE-_-NONE-/
- 75N93019F00257 (delivery order): -$220, National Institutes of Health Niaid. To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N93019F00257_7529_HHSN272201600011I_7529/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/international-aids-vaccine-initiative-inc-zejbc8jqm3p5.